REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer.

J. Chang-Claude | T. Vercauteren | A. Dunning | R. Stock | M. Mareel | P. Seibold | D. de Ruysscher | C. Faivre-Finn | R. Bultijnck | V. Fonteyne | T. Ward | D. Higginson | L. Paelinck | W. De Neve | S. Gutiérrez‐Enríquez | C. West | B. Rosenstein | M. D. De Santis | Y. Lievens | C. Bourgier | J. Fernández-Tajes | A. Choudhury | P. Stegmaier | T. Rancati | R. Valdagni | B. Vanneste | P. Gabriele | M. Brengues | E. Delmastro | B. Avuzzi | J. Classen | P. Ost | M. Kaushik | S. Shokuhi | E. Briers | L. Fachal | A. Vega | A. Gómez-Caamaño | K. Vandecasteele | R. Elliott | C. Talbot | E. Garibaldi | C. Weissenberger | I. Helmbold | C. Herskind | G. Defraene | R. P. Symonds | P. Peleteiro | A. Carballo | P. Calvo-Crespo | Ramón Lobato-Busto | D. Azria | M. Mollà | J. Schäfer | L. Veldeman | M. Lambrecht | A. Cicchetti | F. Duprez | T. Rattay | S. Green | M. Veldwijk | D. Payne | F. Giordano | S. Lavers | A. Webb | C. Sangalli | K. Foweraker | A. Osman | S. Pilgrim | C. Esler | E. Sperk | M. Aguado-Barrera | P. Deseyne | A. van Greveling | C. Monten | L. Lozza | Kerstie Johnson | M. Farcy-Jacquet | A. Müller | G. Post | V. Reyes | T. Schnabel | H. Stobart | B. Taboada-Valladares | M. van Eijkeren | Elhaseen Elhamin | Martijn Swimberghe | R. Aerts | Soumia Arredouani | R. Draghici | U. Giesche | Christian Weiss | Thomas Blaschke | B. Neu | S. Morlino | M. Franceschini | Belina Rodriguez-Lage | Olivia Fuentes-Rios | Isabel Domínguez-Rios | Irene Fajardo-Paneque | Paloma Sosa-Fajardo | Laura Torrado-Moya | Mónica Ramos-Albiac | A. Giraldo | M. Altabás | Bibiana Piqué-Leiva | David García-Relancio | Alejandro Seoane-Ramallo | Simon K. Wright | Hannah Dobbelaere | D. Appleton | F. Kenny | H. Khout | J. Krupa | K. Lambert | K. Valassiadou | L. Aznar-Garcia | Ion Boiangui | K. Kancherla | C. Kent | K. Sampson | T. Sridhar | S. Vasanthan | Victoria Harrop | M. Keni | A. Pascoe | A. Golchin | William Li | A. V. Van Greveling | Miguel E. Aguado-Barrera | M. Altabas | Olivia Fuentes-Ríos | Irmgard Helmbold | Sam Lavers | Renée Bultijnck

[1]  J. Chang-Claude,et al.  Multi-centre technical evaluation of the radiation-induced lymphocyte apoptosis assay as a predictive test for radiotherapy toxicity , 2019, Clinical and translational radiation oncology.

[2]  Gary D Bader,et al.  Association analysis identifies 65 new breast cancer risk loci , 2017, Nature.

[3]  Petra Seibold,et al.  Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  David Gillatt,et al.  Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. , 2016, The New England journal of medicine.

[5]  Joyce E. Wilkinson,et al.  Patient‐reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life , 2016, BJU international.

[6]  H. Thierens,et al.  Pitfalls in Prediction Modeling for Normal Tissue Toxicity in Radiation Therapy: An Illustration With the Individual Radiation Sensitivity and Mammary Carcinoma Risk Factor Investigation Cohorts. , 2016, International journal of radiation oncology, biology, physics.

[7]  Richard Stock,et al.  Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer , 2016, EBioMedicine.

[8]  Annie Gao,et al.  Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial , 2015, The Lancet. Oncology.

[9]  Sébastien Clippe,et al.  Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial☆ , 2015, EBioMedicine.

[10]  A. Dunning,et al.  Incorporating Genetic Biomarkers into Predictive Models of Normal Tissue Toxicity. , 2015, Clinical oncology (Royal College of Radiologists (Great Britain)).

[11]  J. Chang-Claude,et al.  XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients. , 2015, International journal of radiation oncology, biology, physics.

[12]  G. Velikova,et al.  Systematic Review of Radiation Therapy Toxicity Reporting in Randomized Controlled Trials of Rectal Cancer: A Comparison of Patient-Reported Outcomes and Clinician Toxicity Reporting. , 2015, International journal of radiation oncology, biology, physics.

[13]  J. Logue,et al.  Patient-reported outcomes and health-related quality of life in prostate cancer treated with a single fraction of high dose rate brachytherapy combined with hypofractionated external beam radiotherapy. , 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

[14]  Benjamin Movsas,et al.  Patient-reported outcomes and survivorship in radiation oncology: overcoming the cons. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  C. Faivre-Finn,et al.  Investigation of a Patient Reported Outcome tool to assess radiotherapy-related toxicity prospectively in patients with lung cancer. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  Andre Dekker,et al.  Radiogenomics: radiobiology enters the era of big data and team science. , 2014, International journal of radiation oncology, biology, physics.

[17]  Alison M Dunning,et al.  A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1 , 2014, Nature Genetics.

[18]  M. Sydes,et al.  A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  N. Babacan,et al.  The impact of radiotherapy on quality of life for cancer patients: a longitudinal study , 2014, Supportive Care in Cancer.

[20]  P. Lambin,et al.  The REQUITE project: validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality of life in cancer survivors. , 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

[21]  M. de Groot,et al.  The impact of gastrointestinal and genitourinary toxicity on health related quality of life among irradiated prostate cancer patients. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  Joseph O Deasy,et al.  STROGAR – STrengthening the Reporting Of Genetic Association studies in Radiogenomics , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  P. Lambin,et al.  No association between TGF-β1 polymorphisms and radiation-induced lung toxicity in a European cohort of lung cancer patients. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[24]  Petra Seibold,et al.  Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[25]  J Chang-Claude,et al.  A replicated association between polymorphisms near TNFα and risk for adverse reactions to radiotherapy , 2012, British Journal of Cancer.

[26]  M. Sydes,et al.  Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study. , 2012, The Lancet. Oncology.

[27]  Claudio Fiorino,et al.  Inclusion of clinical risk factors into NTCP modelling of late rectal toxicity after high dose radiotherapy for prostate cancer. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[28]  J. Logue,et al.  Development of a patient-reported questionnaire for collecting toxicity data following prostate brachytherapy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[29]  Andrzej Polanski,et al.  Establishment of a Radiogenomics Consortium. , 2010, International journal of radiation oncology, biology, physics.

[30]  E. Yorke,et al.  Improving normal tissue complication probability models: the need to adopt a "data-pooling" culture. , 2010, International journal of radiation oncology, biology, physics.

[31]  F. Bull,et al.  Global physical activity questionnaire (GPAQ): nine country reliability and validity study. , 2009, Journal of physical activity & health.

[32]  R. Swindell,et al.  The impact of radiotherapy late effects on quality of life in gynaecological cancer patients , 2009, British Journal of Cancer.

[33]  C. Ramsay,et al.  A review of RCTs in four medical journals to assess the use of imputation to overcome missing data in quality of life outcomes , 2008, Trials.

[34]  Jaime S. Cardoso,et al.  Turning subjective into objective: the BCCT.core software for evaluation of cosmetic results in breast cancer conservative treatment. , 2007, Breast.

[35]  Geoff Delaney,et al.  The role of radiotherapy in cancer treatment , 2005, Cancer.

[36]  R. Hays,et al.  Estimating clinically significant differences in quality of life outcomes , 2004, Quality of Life Research.

[37]  N. Aaronson,et al.  The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  B. Garssen,et al.  Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy. , 1996, British Journal of Cancer.

[39]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[40]  G. Snow,et al.  The role of radiotherapy , 1980, The Journal of Laryngology & Otology.